These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29170919)

  • 61. Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
    McNaughton AL; D'Arienzo V; Ansari MA; Lumley SF; Littlejohn M; Revill P; McKeating JA; Matthews PC
    Gastroenterology; 2019 Jan; 156(2):384-399. PubMed ID: 30268787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dynamics of a stochastic hepatitis B virus transmission model with media coverage and a case study of China.
    Ma J; Ma S
    Math Biosci Eng; 2023 Jan; 20(2):3070-3098. PubMed ID: 36899572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modeling the transmission dynamics and control of Hepatitis B virus in China.
    Zou L; Zhang W; Ruan S
    J Theor Biol; 2013 Jan; 317():426-7. PubMed ID: 23401881
    [No Abstract]   [Full Text] [Related]  

  • 64. The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda.
    Martyn E; Eisen S; Longley N; Harris P; Surey J; Norman J; Brown M; Sultan B; Maponga TG; Iwuji C; Flanagan S; Ghosh I; Story A; Matthews PC
    Elife; 2023 Feb; 12():. PubMed ID: 36757862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Research progress on the comorbidity between hepatitis B virus infection and noncommunicable diseases].
    Xie JZ; Li TY; Zheng LX; Cai SY; Gu J; Hao YT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Sep; 57(9):1523-1528. PubMed ID: 37743318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Good Practices and Initiatives for the Control and Elimination of Hepatitis B in the World: A Scoping Review.
    Jalal MA; Mohammed LM; Suraifi M; Namdari M; Lami F; Taher TMJ; Anied AA; Etemad K; Karami M
    Cureus; 2024 May; 16(5):e59785. PubMed ID: 38716364
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reply to the letter by Peng. HBV transmission route among children in China.
    Pan XB
    J Viral Hepat; 2020 Apr; 27(4):462. PubMed ID: 31919956
    [No Abstract]   [Full Text] [Related]  

  • 68. Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.
    Liu J; Goicochea P; Block T; Brosgart CL; Donaldson EF; Lenz O; Gee Lim S; Marins EG; Mishra P; Peters MG; Miller V
    J Virus Erad; 2017 Jan; 3(1):1-6. PubMed ID: 28275452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Achievements and challenges in the prevention of mother-to-infant transmission of hepatitis B virus in China].
    Zhou Y; Hu Y
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):15-8. PubMed ID: 25876801
    [No Abstract]   [Full Text] [Related]  

  • 70. Uptake of hepatitis B antiviral treatment: A panel data analysis of 31 provinces in China (2013-2020).
    Cheng H; Liu S; Luo S; Chan P; Chen Z; Le LV; Sun J
    Liver Int; 2022 Aug; 42(8):1762-1769. PubMed ID: 35615902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive.
    Dore GJ; Cowie B
    Clin Infect Dis; 2021 Mar; 72(5):753-754. PubMed ID: 32255492
    [No Abstract]   [Full Text] [Related]  

  • 72. Funding needed for cure research to eliminate hepatitis B.
    Brownstein A; Cohen C
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):149. PubMed ID: 29870728
    [No Abstract]   [Full Text] [Related]  

  • 73. Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges.
    Yan YP; Su HX; Ji ZH; Shao ZJ; Pu ZS
    J Clin Transl Hepatol; 2014 Mar; 2(1):15-22. PubMed ID: 26356070
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Discussion on the prevention and control strategies of chronic hepatitis B: experience from AIDS prevention and control in China].
    Li J; Liu ZF
    Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):402-405. PubMed ID: 38858189
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Guidelines for Prevention and Treatment of Chronic Hepatitis B.
    Wang G; Duan Z
    J Clin Transl Hepatol; 2021 Oct; 9(5):769-791. PubMed ID: 34722192
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gulf Cooperation Council states: On the brink of HBV elimination.
    Lazarus JV; Mark HE; Sanai FM; Hashim A; Farghaly M; Alqahtani SA; Al-Awadhi S
    Liver Int; 2021 Nov; 41(11):2805-2808. PubMed ID: 34562293
    [No Abstract]   [Full Text] [Related]  

  • 77. Special Issue: "Updates on HBV Infection".
    Chemin I; Pujol FH
    Microorganisms; 2022 Mar; 10(3):. PubMed ID: 35336155
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Building the evidence base to eliminate hepatitis B and C as public health threats.
    Ward JW
    Lancet Infect Dis; 2016 Dec; 16(12):1314-1316. PubMed ID: 27615027
    [No Abstract]   [Full Text] [Related]  

  • 79. A Tool to Inform Hepatitis C Elimination: A Case for Hepatitis C Elimination in China.
    Adee M; Zhuo Y; Zhan T; Chen Q; Toumi A; Ayer T; Nwankwo C; Zhong H; Puenpatom A; Chhatwal J
    Clin Liver Dis (Hoboken); 2021 Mar; 17(3):99-106. PubMed ID: 33868647
    [No Abstract]   [Full Text] [Related]  

  • 80. Control of Chronic Hepatitis B in China: Perspective of Diagnosis and Treatment.
    Wang Y; Wang M; Zhang G; Ou X; Ma H; You H; Jia J
    China CDC Wkly; 2020 Jul; 2(31):596-600. PubMed ID: 34594716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.